[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 9/17/2021.[ Price : $8.95]
FDA approves a Neovasc IDE for its COSIRA-II IDE clinical trial that will evaluate the Reducer device and its use in treating cert...[ Price : $8.95]
An FDA advisory committee unanimously votes to recommend Pfizer-BioNTechs Comirnaty Covid-19 booster vaccine in individuals 65 yea...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Questions and Answers on Biosimilar Development and the BPC...[ Price : $8.95]
Pfizer expands its Chantix (varenicline) recall to include all lots of 0.5 mg and 1 mg tablets because of the potential presence o...[ Price : $8.95]
An FDA safety alert warns healthcare professionals and patients not to use compounded products from Prescription Labs, doing busin...[ Price : $8.95]
A Florida federal court enters a consent decree against Premier Pharmacy Labs that prohibits it from producing or distributing any...[ Price : $8.95]
FDA places a clinical hold against three Protagonist Therapeutics clinical studies for rusfertide due to concerning mouse study fi...